S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation.
Saved in:
| Title: | S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation. |
|---|---|
| Authors: | Mithoefer, M.1, Mithoefer, A.2, Feduccia, A.3, Jerome, I.4, Wagner, M.5, Hoilland, J.6, Hamilton, S.7, Yazar-Klosinski, B.8, Emerson, A.9, Doblin, R.10 |
| Source: | European Neuropsychopharmacology. 2019 Supplement1, Vol. 29, pS11-S12. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 134662455 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mithoefer%2C+M%2E%22">Mithoefer, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Mithoefer%2C+A%2E%22">Mithoefer, A.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Feduccia%2C+A%2E%22">Feduccia, A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Jerome%2C+I%2E%22">Jerome, I.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Wagner%2C+M%2E%22">Wagner, M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Hoilland%2C+J%2E%22">Hoilland, J.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Hamilton%2C+S%2E%22">Hamilton, S.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Yazar-Klosinski%2C+B%2E%22">Yazar-Klosinski, B.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Emerson%2C+A%2E%22">Emerson, A.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Doblin%2C+R%2E%22">Doblin, R.</searchLink><relatesTo>10</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Neuropsychopharmacology%22">European Neuropsychopharmacology</searchLink>. 2019 Supplement1, Vol. 29, pS11-S12. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=134662455 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euroneuro.2018.11.930 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S11 Titles: – TitleFull: S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mithoefer, M. – PersonEntity: Name: NameFull: Mithoefer, A. – PersonEntity: Name: NameFull: Feduccia, A. – PersonEntity: Name: NameFull: Jerome, I. – PersonEntity: Name: NameFull: Wagner, M. – PersonEntity: Name: NameFull: Hoilland, J. – PersonEntity: Name: NameFull: Hamilton, S. – PersonEntity: Name: NameFull: Yazar-Klosinski, B. – PersonEntity: Name: NameFull: Emerson, A. – PersonEntity: Name: NameFull: Doblin, R. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 01 Text: 2019 Supplement1 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 0924977X Numbering: – Type: volume Value: 29 Titles: – TitleFull: European Neuropsychopharmacology Type: main |
| ResultId | 1 |
